An interesting relationship between drug absorption and melting point

被引:58
作者
Chu, Katherine A. [1 ]
Yalkowsky, Samuel H. [1 ]
机构
[1] Univ Arizona, Coll Pharm, Tucson, AZ 85721 USA
关键词
Absorption; Absorption potential; Bioavailability; Dose; Fraction absorbed; Melting point; Partition coefficient; Passive absorption; Solubility; Suspension; HUMAN INTESTINAL-ABSORPTION; IN-VITRO MODEL; ORAL ABSORPTION; 3-PHASE SYSTEM; PREDICTION; DISCOVERY; SOLUBILITY; TRANSPORT; FRACTION; SOLUTES;
D O I
10.1016/j.ijpharm.2009.01.026
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The ability to predict the extent of passive intestinal drug absorption is very important for efficient lead candidate selection and development. Physicochemical-based absorption predictive models previously developed use solubility, partition coefficient and pK(a) as drug input parameters for intestinal absorption. Alternatively, this study looks at the relationship between melting point and passive transport for poorly soluble drugs. It is based entirely on the expression derived from the General Solubility Equation (GSE) that relates melting point to the product of intrinsic solubility and partition coefficient. Given that the melting point of a compound is one of the first and more reliable physical properties measured, it can be advantageously used as a guide in early drug discovery and development. This paper elucidates the interesting relationship between the melting point and dose to the fraction absorbed of poorly soluble drugs, i.e., class II and IV compounds in the Biopharmaceutics Classification System. The newly defined melting point based absorption potential (MPbAP) parameter is successful at distinguishing 90% of the 91 drugs considered being well absorbed (FA>0.5) or poorly absorbed. In general, lower melting compounds are more likely to be well absorbed than higher melting compounds for any given dose. The fraction absorbed for drugs with high melting temperatures is limited by the dose to a greater degree than it is for low melting compounds. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:24 / 40
页数:17
相关论文
共 37 条
[1]  
*ACS, 2006, SCIFINDER SCHOL
[2]   Can we learn to distinguish between "drug-like" and "nondrug-like" molecules? [J].
Ajay ;
Walters, WP ;
Murcko, MA .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (18) :3314-3324
[3]   A THEORETICAL BASIS FOR A BIOPHARMACEUTIC DRUG CLASSIFICATION - THE CORRELATION OF IN-VITRO DRUG PRODUCT DISSOLUTION AND IN-VIVO BIOAVAILABILITY [J].
AMIDON, GL ;
LENNERNAS, H ;
SHAH, VP ;
CRISON, JR .
PHARMACEUTICAL RESEARCH, 1995, 12 (03) :413-420
[4]   Drug liposome partitioning as a tool for the prediction of human passive intestinal absorption [J].
Balon, K ;
Riebesehl, BU ;
Müller, BW .
PHARMACEUTICAL RESEARCH, 1999, 16 (06) :882-888
[5]  
*BIOB CORP, 1995, CLOGP WIND 4 0
[6]   A simple approach for indexing the oral druglikeness of a compound: Discriminating druglike compounds from nondruglike ones [J].
Biswas, Dhrubajyoti ;
Roy, Sujata ;
Sen, Srikanta .
JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2006, 46 (03) :1394-1401
[7]   At decision-support tool for the formulation of orally active, poorly soluble compounds [J].
Branchu, Sebastien ;
Roqueda, Philippe G. ;
Plumb, A. Philip ;
Cook, Walter G. .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2007, 32 (02) :128-139
[8]   Physical chemical properties of oral drug candidates in the discovery and exploratory development settings [J].
Curatolo, W .
PHARMACEUTICAL SCIENCE & TECHNOLOGY TODAY, 1998, 1 (09) :387-393
[9]   ABSORPTION POTENTIAL - ESTIMATING THE FRACTION ABSORBED FOR ORALLY-ADMINISTERED COMPOUNDS [J].
DRESSMAN, JB ;
AMIDON, GL ;
FLEISHER, D .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1985, 74 (05) :588-589
[10]   CORRELATION AND PREDICTION OF MASS-TRANSPORT ACROSS MEMBRANES .1. INFLUENCE OF ALKYL CHAIN-LENGTH ON FLUX-DETERMINING PROPERTIES OF BARRIER AND DIFFUSANT [J].
FLYNN, GL ;
YALKOWSKY, SH .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1972, 61 (06) :838-+